John Paulson's investment portfolio showcases a strategic inclination towards pharmaceuticals and resource-based companies. Madrigal Pharmaceuticals Inc, a leader in developing innovative therapies for cardiovascular-metabolic diseases, holds a significant position in Paulson's stocks collection, testifying to his faith in biotech's growth potential. Bausch Health Companies Inc further diversifies his interest in the healthcare sector, with this company being a global provider of diversified pharmaceuticals.
The finance sector is represented through BrightSphere Investment Group Inc, where Paulson sees value in asset management firms. This aligns with a broader investment play on financial services industry dynamics.
Heading into natural resources, Perpetua Resources Corp reflects Paulson's bet on sustainable mining operations, indicating an environmentally conscious yet profitability-focused strategy. Novagold Resources Inc complements this approach with its stake in precious metal exploration—particularly gold—which acts as a hedge against market volatility and inflation.
Paulson's top five investments reveal a balanced mix between high-growth potential pharma and steady-eddy resource sectors, signaling a blended risk appetite to seasoned and novice investors alike.
Q2 2022
Increased shares by 2.3%
Added 2.3% in Q2 2022
Q4 2023
Increased shares by 121.1%
Added 121.1% in Q4 2023
Dec 21, 2021
Sold 8.1% shares
Sold 8.1% on Dec 21, 2021
Q1 2022
Increased shares by 2463.1%
Added 2463.1% in Q1 2022
Q4 2023
Increased shares by 5.9%
Added 5.9% in Q4 2023
Q4 2022
Sold 24.2% shares
Sold 24.2% in Q4 2022
Q4 2022
Sold 6.5% shares
Sold 6.5% in Q4 2022
Jan 18, 2024
Increased shares by 3.7%
Added 3.7% on Jan 18, 2024
Q2 2021
Increased shares by 31.8%
Added 31.8% in Q2 2021
Q4 2023
Increased shares by 133.5%
Added 133.5% in Q4 2023
Q2 2020
New holding
New holding in Q2 2020
Q4 2022
Sold 35.9% shares
Sold 35.9% in Q4 2022
Q2 2019
Sold 50.0% shares
Sold 50.0% in Q2 2019
Jun 26, 2019
Sold 38.1% shares
Sold 38.1% on Jun 26, 2019
Q1 2022
Increased shares by 181.0%
Added 181.0% in Q1 2022
Q3 2022
Sold 23.7% shares
Sold 23.7% in Q3 2022
Q2 2016
Sold -4.45 Million shares
Sold 100% in Q2 2016
Q1 2016
Sold -132 Thousand shares
Sold 100% in Q1 2016
Q2 2013
Sold -4.2 Million shares
Sold 100% in Q2 2013
Q1 2016
Sold -140 Thousand shares
Sold 100% in Q1 2016
Q2 2021
Sold -595 Thousand shares
Sold 100% in Q2 2021
Q4 2015
Sold -5.76 Million shares
Sold 100% in Q4 2015
Q3 2023
Sold -50 Thousand shares
Sold 100% in Q3 2023
Q2 2022
Sold -961 Thousand shares
Sold 100% in Q2 2022
Q3 2022
Sold -7.79 Million shares
Sold 100% in Q3 2022
Q2 2017
Sold -408 Thousand shares
Sold 100% in Q2 2017
Q3 2017
Sold -48.6 Thousand shares
Sold 100% in Q3 2017
Q2 2019
Sold -40 Thousand shares
Sold 100% in Q2 2019
Q3 2017
Sold -240 Thousand shares
Sold 100% in Q3 2017
Q2 2021
Sold -4.73 Million shares
Sold 100% in Q2 2021
Easily embed the chart on your blog or website – it will always update automatically!